Articles by George Koroneos - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by George Koroneos

George Koroneos


George is a former assistant editor of Pharmaceutical Technology.

Articles
Antares Announces TecTix Drug Delivery System
April 27, 2006

On April 24, Antares Pharma (Exton, PA, www.antarespharma.com) unveiled its new ?TecTix? advanced transdermal delivery system for the transport of topical drug and excipients across the skin by changing the melting point of the active ingredient. Whereas previous methods focused on the delivery of the drug through the dermis and directly into the bloodstream, the TecTix method can be used locally for dermatological treatments and local anesthetics.

RFID and the Future of Pharmaceutical Supply Chains
March 24, 2006

RFID and the Future of Pharmaceutical Supply Chains

Proposed Legislation to Help Fight Counterfeit Drugs
March 9, 2006

Proposed Legislation to Help Fight Counterfeit Drugs

GPhA Seeks Additional ODG Funding, Not User Fees
February 24, 2006

GPhA Seeks Additional ODG Funding, Not User Fees

Warning Letter: Southern Meds
February 24, 2006

Warning Letter: Southern Meds

RFID: A Slow Go in Pharmaceutical Adoption
February 16, 2006

The Pharmaceutical Industry has been slow in adopting radio frequency technology (RFID) to help control diversion and counterfeiting, according to a recent study by ABI Research (Oyster Bay, NY, www.abiresearch.com). In fact, only 10 drug products are expected to be shipped with RFID tags or smart chips embedded in the labeling in the coming year.

Non-Injectable Insulins Win Approval: Pfizer in the US, Generex in South America
February 2, 2006

Non-Injectable Insulins Win Approval: Pfizer in the US, Generex in South America

AAIPharma Moves Ahead with Reorganization Plan
January 26, 2006

AAIPharma Moves Ahead with Reorganization Plan

Pfizer Combats Counterfeiters with RFID
January 12, 2006

Pfizer Combats Counterfeiters with RFID

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here